fda glp-1 compounding enforcement september 2025 to Restrict Ingredients Used in Mass-Marketed Compounded GLP-1s, Crack Down on Misleading Ads Did the FDA Ban Compounded

I Asked Telehealth Providers How They Are Adapting to the Compounding GLP-1 Ban Many telehealth providers are taking the FDA guidelines seriously and have stopped offering compounded medications altogether

Table 2 Baseline demography and clinical characteristics of low versus high GLP-1 levels in prediabetes and type 2 diabetes subjects

Insurance coverage varies significantly: Many insurance plans cover GLP-1s when prescribed for type 2 diabetes Coverage for weight management is less consistent and often requires meeting specific criteria (BMI thresholds, documented weight-related health conditions, prior weight loss attempts) Medicare Part D does not cover medications solely for weight loss Some manufacturers offer savings programs or patient assistance programs for eligible patients Check with your insurance provider about coverage criteria and explore manufacturer savings programs if paying out of pocket is a concern

That allows extremely precise implant sizing and positioning